Choong GM, Liddell S, Ferre RAL, O'Sullivan CC, et al. Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study. Breast Cancer Res Treat 2022 Aug 31. pii: 10.1007/s10549-022-06713.
PMID: 36045271